Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Here are the key takeaways from the full Times Magazine story about the F.D.A.: The F.D.A.’s regulators have an enormous ...

Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

In recalls, best-by or use-by dates are commonly provided. Even if the affected date has passed, be sure to check your ...

The REMS program for the ERA drug class was established due to the risk of embryofetal toxicity seen from animal studies.

An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising safety concerns.

In the final days of this year’s legislative session, Idaho lawmakers passed a bill to allow pharmacies to sell ivermectin ...

With the clearance, Mendaera is starting a limited launch of Focalist with select medical institutions this year.